BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Diagnosis
52 results:

  • 1. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
    Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
    Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical significance and immune characteristics analysis of miR-221-3p and its key target genes related to epithelial-mesenchymal transition in breast cancer.
    Fang Y; Zhang Q; Chen Z; Guo C; Wu J
    Aging (Albany NY); 2024 Jan; 16(1):322-347. PubMed ID: 38189813
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Contrast-Enhanced Ultrasound and Conventional Ultrasound Characteristics of breast cancer With Different Molecular Subtypes.
    Li X; Zhang J; Zhang G; Liu J; Tang C; Chen K; Chen P; Tan L; Guo Y
    Clin Breast Cancer; 2024 Apr; 24(3):204-214. PubMed ID: 38102010
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nonlobular Invasive breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
    Derakhshan F; Da Cruz Paula A; Selenica P; da Silva EM; Grabenstetter A; Jalali S; Gazzo AM; Dopeso H; Marra A; Brown DN; Ross DS; Mandelker D; Razavi P; Chandarlapaty S; Wen HY; Brogi E; Zhang H; Weigelt B; Pareja F; Reis-Filho JS
    Mod Pathol; 2024 Feb; 37(2):100375. PubMed ID: 37925055
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A B7-H4-Targeting Antibody-Drug Conjugate Shows Antitumor Activity in PARPi and Platinum-Resistant cancers with B7-H4 Expression.
    Gitto SB; Whicker M; Davies G; Kumar S; Kinneer K; Xu H; Lewis A; Mamidi S; Medvedev S; Kim H; Anderton J; Tang EJ; Ferman B; Coats S; Wilkinson RW; Brown E; Powell DJ; Simpkins F
    Clin Cancer Res; 2024 Apr; 30(8):1567-1581. PubMed ID: 37882675
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Estrogen-induced reactive oxygen species, through epigenetic reprogramming, causes increased growth in breast cancer cells.
    Roy P; Kandel R; Sawant N; Singh KP
    Mol Cell Endocrinol; 2024 Jan; 579():112092. PubMed ID: 37858609
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Nano-matrixes propped self-enhanced electrochemiluminescence biosensor for microRNA detection.
    Sun W; Zhang N; Ren X; Wu D; Jia Y; Wei Q; Ju H
    Biosens Bioelectron; 2023 Dec; 242():115750. PubMed ID: 37844387
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker.
    Takahashi M; Tsuchikawa T; Hiwasa T; Nakamura T; Hontani K; Kushibiki T; Inoko K; Takano H; Hatanaka Y; Matsushita K; Matsubara H; Hoshino T; Ohtsuka M; Shimada H; Tanaka K; Nakanishi Y; Asano T; Noji T; Okamura K; Shichinohe T; Hirano S
    Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562381
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of the Clinicopathologic Features and T-Cell Infiltration of B7-H3 and B7-H4 Expression in Triple-negative breast cancer Subtypes.
    Kim NI; Park MH; Cho N; Lee JS
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):246-256. PubMed ID: 35384874
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Implications for health system resilience: Quantifying the impact of the COVID-19-related stay at home orders on cancer screenings and diagnoses in southeastern North Carolina, USA.
    Carroll R; Duea SR; Prentice CR
    Prev Med; 2022 May; 158():107010. PubMed ID: 35305996
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China.
    Liu X; Davis AA; Xie F; Gui X; Chen Y; Zhang Q; Gerratana L; Zhang Y; Shah AN; Behdad A; Wehbe F; Huang Y; Yu J; Du P; Jia S; Li H; Cristofanilli M
    Breast Cancer Res Treat; 2021 Nov; 190(2):213-226. PubMed ID: 34471951
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Second Malignancies after Radiation Therapy: Update on Pathogenesis and Cross-sectional Imaging Findings.
    Khanna L; Prasad SR; Yedururi S; Parameswaran AM; Marcal LP; Sandrasegaran K; Tirumani SH; Menias CO; Katabathina VS
    Radiographics; 2021; 41(3):876-894. PubMed ID: 33891523
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer.
    Quintana Á; Peg V; Prat A; Moliné T; Villacampa G; Paré L; Galván P; Dientsmann R; Schmid P; Curigliano G; Muñoz-Couselo E; Perez-García J; Marti M; Blanco-Heredia J; Anjos CD; Vazquez M; De Mattos-Arruda L; Cortés J
    Eur J Cancer; 2021 May; 148():134-145. PubMed ID: 33743482
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. miRNA-506-3p Directly Regulates rs10754339 (A/G) in the Immune Checkpoint Protein B7-H4 in breast cancer.
    El Din GS; Youness RA; Assal RA; Gad MZ
    Microrna; 2020; 9(5):346-353. PubMed ID: 33297930
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Peripheral cytotoxic T lymphocyte predicts first-line progression free survival in HER2-positive advanced breast cancer.
    Liu XR; Yu JJ; Song GH; Di LJ; Jiang HF; Yan Y; Liang X; Zhang RY; Ran R; Wang J; Bai H; Jia SD; Li HP
    Breast; 2021 Feb; 55():7-15. PubMed ID: 33296767
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Risk of cancer in Association with Ranitidine and Nizatidine vs Other H2 Blockers: Analysis of the Japan Medical Data Center Claims Database 2005-2018.
    Iwagami M; Kumazawa R; Miyamoto Y; Ito Y; Ishimaru M; Morita K; Hamada S; Tamiya N; Yasunaga H
    Drug Saf; 2021 Mar; 44(3):361-371. PubMed ID: 33247391
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identifying Genomic Alterations in Patients With Stage IV breast cancer Using MammaSeq: An International Collaborative Study.
    Shah OS; Soran A; Sahin M; Knapick BA; Ugras S; Celik E; Lucas PC; Lee AV
    Clin Breast Cancer; 2021 Jun; 21(3):210-217. PubMed ID: 33191115
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia.
    Anwar SL; Avanti WS; Nugroho AC; Choridah L; Dwianingsih EK; Harahap WA; Aryandono T; Wulaningsih W
    World J Surg Oncol; 2020 May; 18(1):117. PubMed ID: 32473643
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A Bioinspired Nanoprobe with Multilevel Responsive T
    Li Y; Zhao X; Liu X; Cheng K; Han X; Zhang Y; Min H; Liu G; Xu J; Shi J; Qin H; Fan H; Ren L; Nie G
    Adv Mater; 2020 Jan; 32(4):e1906799. PubMed ID: 31799765
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Giant cell tumor of soft tissue of the breast: Case report with H3F3A mutation analysis and review of the literature.
    Luangxay T; Osako T; Yonekura R; Sugiura Y; Kikuchi M; Gomi N; Ueno T; Ohno S; Machinami R; Takeuchi K; Akiyama F
    Pathol Res Pract; 2020 Feb; 216(2):152750. PubMed ID: 31784095
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.